Literature DB >> 8196285

Expression of clusterin in human renal diseases.

J Dvergsten1, J C Manivel, R Correa-Rotter, M E Rosenberg.   

Abstract

Clusterin, a glycoprotein with potent cohesive properties, is induced in a wide variety of acute and chronic experimental renal diseases. The purpose of this study was to examine clusterin expression in human renal diseases. Clusterin immunostaining was examined in nephrectomy specimens from patients with autosomal-dominant polycystic kidney disease (N = 5), autosomal-recessive polycystic kidney disease (N = 3), multilocular cyst of the kidney (N = 2), renal hypoplasia/dysplasia (N = 7), Wilms' tumor (nephroblastoma) (N = 6), renal cell carcinoma (N = 9), and acute and/or chronic renal transplant rejection (N = 15). No clusterin staining was detected in normal renal tissue distant from renal cell carcinomas. Increased expression of clusterin was found in epithelial cells lining cysts in all of the cystic disorders studied. Clusterin expression was found in some immature tubules in hypoplastic/dysplastic kidneys and in tubules of rejected renal allografts, but was not a prominent finding in renal neoplasms, although some renal cell carcinomas expressed clusterin in a focal manner. Common features of clusterin induction included exclusively epithelial production of clusterin in cysts, immature nephrons, and injured tubules, heterogeneity of clusterin expression, with only some tubules and/or cysts in a given area staining for clusterin, and uniform clusterin staining of epithelial cells in a given tubule or cyst in most cases. Based on its cohesive properties, we speculate clusterin functions to maintain cell-cell and cell-substratum interactions which become perturbed in the setting of renal injury and cystic diseases.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8196285     DOI: 10.1038/ki.1994.109

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  15 in total

1.  Proteomic candidate biomarkers of drug-induced nephrotoxicity in the rat.

Authors:  Rodney Rouse; Justyna Siwy; William Mullen; Harald Mischak; Jochen Metzger; Joseph Hanig
Journal:  PLoS One       Date:  2012-04-11       Impact factor: 3.240

Review 2.  Biomarkers for drug-induced renal damage and nephrotoxicity-an overview for applied toxicology.

Authors:  Tobias Christian Fuchs; Philip Hewitt
Journal:  AAPS J       Date:  2011-10-04       Impact factor: 4.009

3.  Utility of Urinary Biomarkers in Predicting Loss of Residual Renal Function: The balANZ Trial.

Authors:  Yeoungjee Cho; David W Johnson; David A Vesey; Carmel M Hawley; Margaret Clarke; Nicholas Topley
Journal:  Perit Dial Int       Date:  2014-04-07       Impact factor: 1.756

4.  Chemosensitization of human renal cell cancer using antisense oligonucleotides targeting the antiapoptotic gene clusterin.

Authors:  T Zellweger; H Miyake; L V July; M Akbari; S Kiyama; M E Gleave
Journal:  Neoplasia       Date:  2001 Jul-Aug       Impact factor: 5.715

5.  Tubular up-regulation of clusterin mRNA in murine lupus-like nephritis.

Authors:  S Moll; P A Menoud; L French; A P Sappino; Y Pastore; J A Schifferli; S Izui
Journal:  Am J Pathol       Date:  1998-04       Impact factor: 4.307

6.  Clusterin promotes the aggregation and adhesion of renal porcine epithelial cells.

Authors:  J R Silkensen; K M Skubitz; A P Skubitz; D H Chmielewski; J C Manivel; J A Dvergsten; M E Rosenberg
Journal:  J Clin Invest       Date:  1995-12       Impact factor: 14.808

7.  Delayed administration of pyroglutamate helix B surface peptide (pHBSP), a novel nonerythropoietic analog of erythropoietin, attenuates acute kidney injury.

Authors:  Nimesh S A Patel; Hannah L Kerr-Peterson; Michael Brines; Massimo Collino; Mara Rogazzo; Roberto Fantozzi; Elizabeth G Wood; Florence L Johnson; Muhammad M Yaqoob; Anthony Cerami; Christoph Thiemermann
Journal:  Mol Med       Date:  2012-05-09       Impact factor: 6.354

8.  Identification and localization of polycystin, the PKD1 gene product.

Authors:  L Geng; Y Segal; B Peissel; N Deng; Y Pei; F Carone; H G Rennke; A M Glücksmann-Kuis; M C Schneider; M Ericsson; S T Reeders; J Zhou
Journal:  J Clin Invest       Date:  1996-12-15       Impact factor: 14.808

Review 9.  Urinary kidney biomarkers for early detection of nephrotoxicity in clinical drug development.

Authors:  Leonie van Meer; Matthijs Moerland; Adam F Cohen; Jacobus Burggraaf
Journal:  Br J Clin Pharmacol       Date:  2014-06       Impact factor: 4.335

10.  Clusterin expression in non-neoplastic adenohypophyses and pituitary adenomas: cytoplasmic clusterin localization in adenohypophysis is related to aging.

Authors:  A Işin Doğan Ekici; Bülent Eren; Nursel Türkmen; Nil Comunoğlu; Recep Fedakar
Journal:  Endocr Pathol       Date:  2008       Impact factor: 3.943

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.